The enrichment of genes associated with MYC-targets might indicate that deregulation of gene expression by MYCN could be an important factor in retinoblastoma development, strengthened by rare retinoblastoma entities in which MYCN amplification substitutes for mutational RB1 inactivation [4]. This evidence concerns the gene RB1 and retinoblastoma.